Skip to content
★ Sign in to follow
DJ

David J. Grainger

Responsable de l'Innovation
Total declarations
11
Company
1
▲ Purchases (1 ops.)
€223k
▼ Sales (2 ops.)
€21k

Latest filing published 02 Jan 2024 for Centessa Pharmaceuticals plc, €34k.

Filing timeline

BuySale
David J. Grainger

Insider track record

Disclosed buys
1
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-19.9%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

David J. Grainger: trading record in brief

This profile gathers the share dealings of David J. Grainger in Centessa Pharmaceuticals plc. The record holds 11 filings, for trades running from 28 January 2022 to 31 December 2023.

The open-market side counts 1 purchase for €223k alongside 2 sales for €21k. On balance, insiders were net buyers of €202k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 8 share grants.

On 2 January 2024 came the latest disclosure, a share grant for €34k in Centessa Pharmaceuticals plc. The clock since the last published purchase (1 February 2022) now reads 1,741 days. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to David J. Grainger

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations10 total

10 of 10 declarations